$55.55
-8.05-12.66%
Last update: Nov 6, 7:23 AM
Cytokinetics Inc
CYTKNASDAQ
The average analyst price target for Cytokinetics is $100.08, 79.4% above the current price. Of 21 analysts, 20 rate it Buy and 1 Hold. Targets range from $56 to $140. The latest change came on Nov 5, 2026, when Citigroup raised its price target on Cytokinetics from $99 to $105 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 21 Analysts
Rating Trend — Last 9 Months
